Point Mutation — Base-Level Genetic Change

Q1 — Sample Band 6 response (8 marks), annotated

A point mutation is a change at base level in the DNA sequence — one base substituted, inserted or deleted. The biological effect, however, is determined at the protein level, so to judge the claim we must look at both mutation type and position. [1 — defines point mutation; introduces the two-axis framework]

Mutation type sets the upper limit on disruption. A substitution leaves the reading frame intact and at worst changes one codon, producing a silent, missense or nonsense outcome. A single-base insertion or deletion shifts the reading frame from the mutation site onward, regrouping every downstream codon — a frameshift. Insertions or deletions of three bases are special: they preserve the reading frame and add or remove one amino acid, so they behave more like substitutions in their reach. [1 — distinguishes the three types with explicit reading-frame logic; 1 — links to the four codon-level outcomes silent/missense/nonsense/frameshift]

Position sets the actual size of the consequence. A frameshift at codon 20 of a 480-amino-acid enzyme generates a premature stop after about half a dozen residues, producing an almost completely non-functional protein. The same frameshift at codon 470 changes only the final 10 residues, leaving the catalytic core intact. A missense in a flexible surface loop may be tolerated; the same missense in an active site or folding nucleus can disable the protein. [1 — uses position explicitly to modulate outcome, with frameshift example near start vs end]

Named examples. In sickle-cell anaemia, a single GAG → GUG substitution in codon 6 of HBB replaces glutamate with valine. The mutation type is mild (substitution, missense) but its position exposes a hydrophobic patch that drives haemoglobin polymerisation under low oxygen, dramatically distorting red blood cell shape. In Duchenne muscular dystrophy, a single-base deletion early in DMD introduces a frameshift roughly 20 codons later, truncating almost the entire dystrophin protein and abolishing function. Here the mutation type itself is severe and the early position makes it worse. In cystic fibrosis ΔF508, a three-base deletion removes a single phenylalanine from CFTR without any frameshift — the type is mild and most of the protein is intact, yet the specific deleted residue disrupts folding badly enough to make the channel be degraded. [1 — at least two named examples used to illustrate type-vs-position interaction]

Judgement. The claim that effect "depends more on position than on type" is partly defensible but overstated. Type sets the kind of damage possible (single amino-acid change vs whole-downstream regrouping), and position sets how much of the protein is affected and whether a critical region is hit. A frameshift can be dangerous anywhere because it usually generates a premature stop, but if the frameshift is in the very last few codons even this is tolerable. A substitution is usually mild but can still be catastrophic if it lands at an active site, as in sickle cell. Neither axis dominates — the effect of a point mutation is a joint function of mutation type AND position within the protein. [1 — explicit judgement that integrates both axes rather than choosing one; 1 — links back to the lesson's "type + position + protein context" framing and rejects a single-factor answer]

Marking criteria.

• 1 mark — Defines point mutation as a base-level DNA change and signals that effect depends on more than one factor.
• 1 mark — Distinguishes substitution, insertion and deletion at the base-sequence / reading-frame level (including 3-base indels not shifting frame).
• 1 mark — Links the three mutation types to the four codon-level outcomes: silent, missense, nonsense, frameshift.
• 1 mark — Uses position explicitly: early frameshift / active-site missense vs late frameshift / surface missense.
• 1 mark — Uses at least two named biological examples drawn from the lesson or Worksheet 2 (e.g. HbS sickle cell, ΔF508 CFTR, DMD frameshift, Tay–Sachs nonsense) and ties each to type AND position.
• 1 mark — Reaches an explicit assessment of the original claim (not just description).
• 1 mark — Judgement integrates BOTH axes — rejects "type only" or "position only" framings.
• 1 mark — Uses precise lesson terminology throughout (codon, reading frame, frameshift, silent/missense/nonsense) and connects to the lesson's DNA → codon → amino acid → protein → phenotype chain.

Q2 — Sample Band 6 response (9 marks), annotated

The claim that "a point mutation must be either harmful or harmless" is a false dichotomy: the sickle-cell case shows that the same point mutation can be harmful, harmless or beneficial depending on genotype and environment. [1 — early judgement that rejects the dichotomy]

The HbS mutation is a substitution at codon 6 of the HBB gene: GAG (Glu) → GUG (Val) — a missense mutation that replaces a polar, charged glutamate with a non-polar, hydrophobic valine on the surface of the β-globin chain. [1 — precise classification including type, codon-level outcome and amino-acid change]

In HbS/HbS homozygotes, every β-globin molecule carries the valine substitution. Under low oxygen, the hydrophobic valine residues on adjacent haemoglobin molecules associate, driving polymerisation into long fibres inside red blood cells. Cells distort into the rigid sickle shape, block capillaries, are removed prematurely by the spleen and cause anaemia, pain crises and organ damage. Here the mutation is clearly harmful. [1 — protein-to-phenotype chain for the homozygote]

In HbA/HbS heterozygotes, only about half the β-globin chains carry the valine substitution. Most haemoglobin behaves normally; some sickling can occur under extreme low-oxygen stress but routine oxygen transport is largely unaffected. Carriers are typically clinically healthy under normal conditions — by themselves, an "intermediate" effect of the same point mutation. [1 — explains why genotype modulates the same mutation]

The environment changes the verdict again. Plasmodium falciparum reproduces poorly inside red blood cells that contain HbS haemoglobin — partly because such cells are removed faster by the spleen when parasitised. In malaria-endemic regions, HbA/HbS heterozygotes therefore survive severe malaria far better than HbA/HbA homozygotes. The "harmful" allele becomes protective in the right environment, which is why HbS reaches 10–20% frequency in sub-Saharan Africa despite the severe homozygous cost. In a malaria-free environment, that benefit disappears and only the homozygous cost remains, so allele frequency drops over generations. [1 — explicit environmental modulation linking HbS frequency to malaria]

This extends the lesson's framework — that a point mutation's effect depends on type, position and protein context — to genotype (homozygote vs heterozygote) and environment (malarial vs non-malarial). The same single base substitution can be (i) harmful in HbS/HbS, (ii) effectively neutral or beneficial in HbA/HbS under malaria pressure, and (iii) mildly disadvantageous in HbA/HbS in a malaria-free environment. None of these can be predicted from "mutation type" alone. [1 — extends the lesson's framework explicitly to genotype + environment]

The claim is therefore rejected. A point mutation is not categorically "harmful or harmless"; its biological effect is the joint product of mutation type, position in the protein, protein context, genotype, and the environment the organism lives in. [1 — final judgement that integrates all four/five factors]

Marking criteria.

• 1 mark — States an evaluative judgement that rejects the harmful/harmless dichotomy.
• 1 mark — Precisely classifies the HbS mutation (substitution, missense, codon 6 GAG → GUG, Glu → Val).
• 1 mark — Connects the amino-acid change (polar to non-polar) to haemoglobin polymerisation and red blood cell sickling.
• 1 mark — Describes the homozygote phenotype (sickling, anaemia, pain crises, capillary blockage).
• 1 mark — Explains why heterozygotes are largely healthy under normal conditions (only ~50% HbS chains, mostly normal Hb function).
• 1 mark — Explains the malaria-resistance mechanism in heterozygotes (poor P. falciparum reproduction in HbS-containing cells; faster splenic clearance).
• 1 mark — Uses HbS allele frequency (10–20% in sub-Saharan Africa) to show that selection environment changes whether the same mutation is favoured or selected against.
• 1 mark — Explicitly extends the lesson's "type + position + protein context" framework to genotype and environment.
• 1 mark — Reaches a justified integrated judgement (the same point mutation can be harmful, neutral or beneficial depending on genotype × environment) using precise lesson terminology throughout.